Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. (Q36979035)
Jump to navigation
Jump to search
scientific article published on September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. |
scientific article published on September 2008 |
Statements
1 reference
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95. (English)
1 reference
David T Curiel
1 reference
Paul Dent
1 reference
Margaret A Park
1 reference
Guo Zhang
1 reference
Clint Mitchell
1 reference
Mohamed Rahmani
1 reference
Hossein Hamed
1 reference
Michael P Hagan
1 reference
Adly Yacoub
1 reference
Paul B Fisher
1 reference
Steven Grant
1 reference
1 reference
1 reference
Identifiers
1 reference